In the absence of advanced fibrosis, family history of HCC, or other risk factors for disease progression, current practice guidelines recommend the initiation of antiviral therapy in select stages of HBV where viral levels and ALT levels are elevated. Here, GPT is linked to hepatocellular carcinoma.